When does the Zelboraf (vemurafenib) patent expire?
No specific patent expiration date is provided in the information available here, so the exact Zelboraf patent expiration date can’t be stated reliably without the relevant patent numbers or jurisdiction details (patent terms can differ by country and by individual patents covering different aspects such as the compound, formulations, or methods of use).
Which country’s patent expiry date matters?
Zelboraf’s “expiration” depends on where you mean:
- US patents (with terms that can be affected by patent term adjustments and regulatory exclusivity)
- EU/UK national patents
- Other jurisdictions (each with its own filing dates and term rules)
To give the correct date, you would need the country (or patent office) you’re checking.
Is it the patent term or exclusivity that ends first?
Even when a patent expires, exclusivity protections (such as regulatory data/exclusivity periods) can delay generic or biosimilar entry. Determining the practical “can competitors launch?” date usually requires checking both:
- the latest relevant patent(s), and
- applicable regulatory exclusivity in that jurisdiction.
What I need to look up the exact date
If you share any of the following, the expiration date can be pinned down precisely:
- the jurisdiction (e.g., US, UK, EP)
- the patent number(s)
- or a link to the patent listing you’re using
Sources
No sources were provided with your question, so I can’t cite any authoritative patent-expiration information.